Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Cephalon Making Progress - Analyst Blog
Dec 01, 2008 05:00 PM
- Pre Market Stock News Brief
Dec 01, 2008 10:05 AM
- ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
Nov 13, 2008 09:30 AM
- Noteworthy Developments in Biotech - Zacks Analyst Interviews
Nov 03, 2008 01:05 PM
- Acusphere Strikes a Partnership - Analyst Blog
Oct 31, 2008 02:44 PM
- Eurand NV Strong with Zentase - Analyst Blog
Oct 27, 2008 06:42 PM
- Biotechs: Buy The Big Dip Phase?
Sep 29, 2008 12:34 PM
- SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial
Aug 28, 2008 06:41 PM
- Institutional Money Flocking in Biotech
Aug 15, 2008 01:23 PM
- Analyst Comments: Corrections Corp, Alnylam Pharma, Ryland, Eurand Pharma, HCP
Aug 11, 2008 12:23 PM
- Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Nov 26, 2008 08:31 AM
- Cephalon and ImmuPharma Sign a $15 million Option Agreement for Late- Stage Experimental Lupus Medication
Nov 25, 2008 08:50 AM
- Cephalon Added to S&P 500 Today
Nov 14, 2008 08:51 AM
- Standard & Poor's Announces Changes to U.S. Indices
Nov 11, 2008 06:24 PM
- Gabelli & Company to Host Inaugural Best Ideas Conference
Nov 11, 2008 08:48 AM
- Zacks Analyst Blog Highlights: Sprint Nextel Corp., Ultrapar Participacoes SA, Eurand N.V., Cephalon, Inc. And GlaxoSmithKline Inc.
Nov 11, 2008 07:18 AM
- Video: Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Nov 03, 2008 08:04 AM
- Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Oct 31, 2008 04:56 PM
- Cephalon, Inc. to Webcast Analyst Day
Oct 30, 2008 01:26 PM
- Cephalon Reports Another Strong Quarter
Oct 28, 2008 04:16 PM
- Form 4 CEPHALON INC For: Sep 19 Filed by: BALDINO FRANK JR (10K)
Sep 23, 2008 03:02 PM
- Form 4 CEPHALON INC For: Aug 11 Filed by: Russell Lesley (10K)
Aug 13, 2008 03:27 PM
- Form 4 CEPHALON INC For: Aug 11 Filed by: ROCHE ROBERT P JR (10K)
Aug 13, 2008 02:54 PM
- Form 4 CEPHALON INC For: Aug 07 Filed by: VAUGHT JEFFRY L (10K)
Aug 11, 2008 03:11 PM
- Form 4 CEPHALON INC For: Aug 04 Filed by: GREBOW PETER E (10K)
Aug 05, 2008 10:53 AM
- Form 4 CEPHALON INC For: Aug 04 Filed by: WILENSKY GAIL R (10K)
Aug 05, 2008 10:53 AM
- Form 4 CEPHALON INC For: Aug 01 Filed by: GREENACRE MARTYN D (10K)
Aug 04, 2008 10:31 AM
- Form 4 CEPHALON INC For: May 22 Filed by: KAILIAN VAUGHN M (10K)
May 27, 2008 05:07 PM
- Form 4 CEPHALON INC For: May 22 Filed by: SANDERS CHARLES A (10K)
May 27, 2008 05:06 PM
- Form 4 CEPHALON INC For: May 22 Filed by: MOLEY KEVIN E (10K)
May 27, 2008 05:06 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
CEPH
|
Compare to S&P
|
| YTD |
2.40 %
|
67.76 %
|
| 4 Weeks |
2.45 %
|
10.74 %
|
| 12 Weeks |
-5.03 %
|
31.64 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 4.42 %
|
|
EPS Growth in Last Year: 28.26 %
|
|
Sales Growth in Last Quarter: 1.17 %
|
|
Sales Growth in Last Quarter: 13.70 %
|
|
|
